SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-21-000023
Filing Date
2021-11-09
Accepted
2021-11-09 16:10:13
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20210930.htm   iXBRL 10-Q 1886610
2 EX-31.1 a3q2021-ex311.htm EX-31.1 9714
3 EX-31.2 a3q2021-ex312.htm EX-31.2 9682
4 EX-32.1 a3q2021-ex321.htm EX-32.1 7371
  Complete submission text file 0001746473-21-000023.txt   6970321

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20210930.xsd EX-101.SCH 52920
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20210930_cal.xml EX-101.CAL 45330
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20210930_def.xml EX-101.DEF 269632
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20210930_lab.xml EX-101.LAB 589692
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20210930_pre.xml EX-101.PRE 408867
10 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20210930_htm.xml XML 972037
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 211392209
SIC: 2834 Pharmaceutical Preparations